EFG Asset Management Americas Corp. Has $1.53 Million Stake in Johnson & Johnson (NYSE:JNJ)

Share on StockTwits

EFG Asset Management Americas Corp. lowered its position in Johnson & Johnson (NYSE:JNJ) by 17.8% during the third quarter, Holdings Channel reports. The firm owned 10,255 shares of the company’s stock after selling 2,221 shares during the period. EFG Asset Management Americas Corp.’s holdings in Johnson & Johnson were worth $1,527,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Winslow Evans & Crocker Inc. lifted its stake in shares of Johnson & Johnson by 0.3% in the 2nd quarter. Winslow Evans & Crocker Inc. now owns 21,603 shares of the company’s stock valued at $3,037,000 after purchasing an additional 69 shares during the last quarter. Lathrop Investment Management Corp lifted its stake in shares of Johnson & Johnson by 1.4% in the 2nd quarter. Lathrop Investment Management Corp now owns 4,901 shares of the company’s stock valued at $689,000 after purchasing an additional 69 shares during the last quarter. Reik & CO. LLC lifted its stake in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Reik & CO. LLC now owns 17,727 shares of the company’s stock valued at $2,493,000 after purchasing an additional 70 shares during the last quarter. Delta Investment Management LLC lifted its stake in shares of Johnson & Johnson by 1.0% in the 2nd quarter. Delta Investment Management LLC now owns 7,406 shares of the company’s stock valued at $1,041,000 after purchasing an additional 71 shares during the last quarter. Finally, IFG Advisory LLC lifted its stake in shares of Johnson & Johnson by 0.4% in the 2nd quarter. IFG Advisory LLC now owns 16,170 shares of the company’s stock valued at $2,274,000 after purchasing an additional 71 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

In other news, EVP Kathryn E. Wengel sold 16,115 shares of the stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $153.52, for a total value of $2,473,974.80. Following the transaction, the executive vice president now owns 66,658 shares in the company, valued at approximately $10,233,336.16. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.27% of the company’s stock.

JNJ has been the topic of several research reports. Credit Suisse Group increased their target price on Johnson & Johnson from $163.00 to $168.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 14th. Stifel Nicolaus lowered Johnson & Johnson from a “buy” rating to a “hold” rating in a research note on Wednesday, August 19th. Raymond James reissued a “buy” rating on shares of Johnson & Johnson in a research note on Friday. Cantor Fitzgerald increased their target price on Johnson & Johnson from $168.00 to $180.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 14th. Finally, ValuEngine raised Johnson & Johnson from a “sell” rating to a “hold” rating in a research note on Monday, August 3rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and ten have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $164.93.

Shares of NYSE JNJ opened at $146.36 on Friday. The stock’s 50-day moving average is $145.51 and its two-hundred day moving average is $146.57. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.48 and a quick ratio of 1.24. Johnson & Johnson has a 1-year low of $109.16 and a 1-year high of $157.00. The company has a market cap of $385.30 billion, a price-to-earnings ratio of 23.01, a price-to-earnings-growth ratio of 3.04 and a beta of 0.69.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Sunday, October 18th. The company reported $2.20 EPS for the quarter, beating analysts’ consensus estimates of $1.98 by $0.22. Johnson & Johnson had a return on equity of 34.64% and a net margin of 21.01%. The business had revenue of $21.08 billion for the quarter, compared to the consensus estimate of $20.15 billion. During the same quarter in the prior year, the business posted $2.12 EPS. The business’s revenue for the quarter was up 1.7% on a year-over-year basis. Equities research analysts anticipate that Johnson & Johnson will post 7.99 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 24th will be issued a $1.01 dividend. The ex-dividend date is Monday, November 23rd. This represents a $4.04 dividend on an annualized basis and a dividend yield of 2.76%. Johnson & Johnson’s payout ratio is currently 46.54%.

About Johnson & Johnson

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR.

Featured Article: What is the definition of market timing?

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Johnson & Johnson  Shares Bought by Sector Gamma AS
Johnson & Johnson Shares Bought by Sector Gamma AS
Ramsay Stattman Vela & Price Inc. Acquires 905 Shares of Johnson & Johnson
Ramsay Stattman Vela & Price Inc. Acquires 905 Shares of Johnson & Johnson
State Board of Administration of Florida Retirement System Has $528.82 Million Stock Position in Johnson & Johnson
State Board of Administration of Florida Retirement System Has $528.82 Million Stock Position in Johnson & Johnson
EFG Asset Management Americas Corp. Has $1.53 Million Stake in Johnson & Johnson
EFG Asset Management Americas Corp. Has $1.53 Million Stake in Johnson & Johnson
Livforsakringsbolaget Skandia Omsesidigt Sells 1,900 Shares of Johnson & Johnson
Livforsakringsbolaget Skandia Omsesidigt Sells 1,900 Shares of Johnson & Johnson
National Asset Management Inc. Has $545,000 Stock Holdings in Booking Holdings Inc.
National Asset Management Inc. Has $545,000 Stock Holdings in Booking Holdings Inc.


 
© 2006-2020 Zolmax.